Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
175.35B
Market cap175.35B
Price-Earnings ratio
31.94
Price-Earnings ratio31.94
Dividend yield
2.47%
Dividend yield2.47%
Average volume
13.49M
Average volume13.49M
High today
$102.13
High today$102.13
Low today
$99.01
Low today$99.01
Open price
$100.99
Open price$100.99
Volume
19.91M
Volume19.91M
52 Week high
$137.49
52 Week high$137.49
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $100.56. The company's market cap stands at 175.35B, with a P/E ratio of 31.94 and a dividend yield of 2.47%.

During the trading session on 2026-07-17, Abbott(ABT) shares reached a daily high of $102.13 and a low of $99.01. At a current price of $100.56, the stock is +1.6% higher than the low and still -1.5% under the high.

Trading activity shows a volume of 19.91M, compared to an average daily volume of 13.49M.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.

ABT News

Benzinga 8h
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results

Abbott Laboratories (NYSE:ABT) reported upbeat second-quarter results and raised its full-year adjusted earnings outlook on Thursday. Adjusted earnings came in...

These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results
TipRanks 9h
Abbott price target raised to $115 from $102 at BofA

BofA analyst Travis Steed raised the firm’s price target on Abbott (ABT) to $115 from $102 and keeps a Buy rating on the shares. Q2 results were “better than fe...

Simply Wall St 18h
Abbott Laboratories Could Be 15% Undervalued On Raised 2026 Earnings Outlook

Abbott Laboratories (ABT) is back in focus after second quarter 2026 earnings topped market expectations, powered by Medical Devices and Diagnostics, and a high...

Abbott Laboratories Could Be 15% Undervalued On Raised 2026 Earnings Outlook

Analyst ratings

79%

of 28 ratings
Buy
78.6%
Hold
21.4%
Sell
0%

More ABT News

Nasdaq 19h
Why Abbott Stock Jumped Today

Key Points Demand for Abbott's medical devices and diagnostic tests is rising. The company has increased its dividend for 54 straight years. 10 stocks we lik...

Why Abbott Stock Jumped Today
TipRanks 22h
Abbott Laboratories Earnings Call Signals Broad-Based Momentum

Abbott Laboratories ((ABT)) has held its Q2 earnings call. Read on for the main highlights of the call. TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has ent...

Benzinga 1d
Abbott Brushes Off Procedure Volume Concerns, Lifts Outlook

Adjusted earnings came in at $1.31 per share, topping the analyst consensus estimate of $1.28. Revenue increased 13% year over year to $12.59 billion, ahead of...

Abbott Brushes Off Procedure Volume Concerns, Lifts Outlook
The Motley Fool 1d
Dow Jones Hangs On While Memory Chips Take Another Beating

The semiconductor sell-off that began Monday in Seoul extended into a fourth consecutive session on Thursday. The tech-heavy indexes lagged while the Dow nearly...

Dow Jones Hangs On While Memory Chips Take Another Beating
TipRanks 1d
Abbott Laboratories Stock Rallies on a Q2 Earnings Beat and a 2026 EPS Guidance Increase

Abbott Laboratories (ABT) stock was on the rise Thursday as investors reacted positively to the healthcare company’s Q2 2026 earnings report. That report includ...

MarketWatch 1d
Healthcare sector is having a moment, driven by strong earnings reports

Healthcare sector is having a moment, driven by strong earnings reports The healthcare sector is the day's strongest, with strong earnings from UnitedHealth an...

Healthcare sector is having a moment, driven by strong earnings reports
Benzinga 1d
Abbott Stock's Best Day Ever: +13.6% On Earnings Beat, Guidance Raise

A three-cent earnings beat and a narrow guidance raise unlocked the largest single-day advance the stock has ever recorded. Shares of Abbott Laboratories jumpe...

Abbott Stock's Best Day Ever: +13.6% On Earnings Beat, Guidance Raise

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.